Related Experiment Video
Updated: Aug 1, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Bridge to recovery using an Impella 2.5 device in a 3-year-old child
Kira Kuschnerus1,2, Christoph Starck3, Evgenij Potapov3
1Department of Congenital Heart Surgery-Pediatric Heart Surgery, German Heart Center Berlin, Berlin, Germany.
Insights
Mechanical circulatory support is limited for pediatric acute left ventricular failure. A 3-year-old child with post-transplant rejection was successfully bridged to recovery using a novel Impella 2.5 device.
Area of Science:
- Pediatric cardiology
- Mechanical circulatory support
- Cardiac transplantation
Background:
- Mechanical support for pediatric acute left ventricular failure is limited, primarily to extracorporeal life support (ECLS) or ventricular assist devices (VADs).
- Acute humoral rejection post-cardiac transplantation can lead to persistent low cardiac output syndrome, posing significant management challenges in children.
Observation:
- A 3-year-old child (12 kg) presented with persistent low cardiac output syndrome due to acute humoral rejection after cardiac transplantation, unresponsive to medical therapy.
- The clinical team opted for an alternative mechanical support strategy due to the limitations of conventional options.
Findings:
- A 2.5 version of the Impella device was successfully implanted using a 6-mm Hemashield prosthesis in the right axillary artery.
- This intervention effectively stabilized the patient's hemodynamics, providing crucial support.
Implications:
- This case demonstrates the potential utility of the Impella 2.5 device as a bridge to recovery in pediatric patients experiencing severe low cardiac output syndrome post-cardiac transplantation.
- The successful application highlights a potentially viable alternative mechanical circulatory support option in challenging pediatric cardiac scenarios.
- Further investigation into the use of percutaneous ventricular assist devices in pediatric transplantation is warranted.
Abstract:
Mechanical support options for children and small adolescents with acute left ventricular failure are often limited to extracorporeal life support (ECLS) and subsequent left ventricular assist device implantation. We report a case of a 3-year-old child weighing 12 kg with acute humoral rejection after cardiac transplantation not adequately responding to medical therapy who presented in persistent low cardiac output syndrome. We successfully stabilized the patient by implanting a Impella 2.5 device via a 6-mm Hemashield prosthesis on the right axillary artery. The patient was bridged to recovery.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis III: Medical Management
Cardiopulmonary Resuscitation I: Adult
Mitral Regurgitation III: Medical Management

